Clinical Trial Update: Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant therapy with docetaxel and cisplatin plus chemoradiotherapy followed by surgery for locally advanced, resectable esophage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED